Human liver oxidative metabolism of O6-benzylguanine
- 1 October 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (9) , 1385-1389
- https://doi.org/10.1016/0006-2952(95)02019-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitroBiochemical Pharmacology, 1994
- Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafyllineChemical Research in Toxicology, 1993
- Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-BIS(2-chloroethyl)-1-nitrosourea(BCNU)Biochemical Pharmacology, 1993
- Synergistic efficacy of O6benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU aloneBiochemical Pharmacology, 1993
- Enhancement of Nitrosourea Activity in Medulloblastoma and Glioblastoma MultiformeJNCI Journal of the National Cancer Institute, 1992
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.British Journal of Clinical Pharmacology, 1990
- Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjectsBiochemical Pharmacology, 1988
- Molybdenum Hydroxylases as Drug-Metabolizing EnzymesDrug Metabolism Reviews, 1985
- [6] Statistical analysis of enzyme kinetic dataPublished by Elsevier ,1979